Gelonghui, October 22 | Harbin Gloria Pharmaceuticals (002437.SZ) surged more than 7% in early trading, now trading at 2.26 yuan, with a total market value of 5.15 billion yuan. The company announced after trading hours yesterday that, based on confidence in the company's future continuous development and recognition of the company's value, it plans to buy back shares worth 50 million yuan to -0.1 billion yuan. The company believes that through this share buyback activity, it not only can effectively enhance the EPS level and strengthen the intrinsic value of the enterprise, but also greatly inspire the enthusiasm and creativity of all employees, collectively driving the company towards a new glory. In addition, this is also beneficial for maintaining price stability in the secondary market and protecting the interests of small and medium shareholders. (Gelonghui)